The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Thrombocythemia, Essential

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Thrombocythemia, Essential.
Olatoyosi Odenike
Connection Strength
0.361
Thrombocythemia, Essential
  1. Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat. Haematologica. 2021 09 01; 106(9):2397-2404.
    View in: PubMed
    Score: 0.206
  2. Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. N Engl J Med. 2015 Sep 03; 373(10):920-8.
    View in: PubMed
    Score: 0.136
  3. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res. 2007 Jun; 31(6):737-40.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.